Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
HHS cancels contracts for largest women’s health effort in US
The Women's Health Initiative study began in 1991 and now includes centers across New York, Boston, Ohio, North Carolina, California and Seattle.
Darren Incorvaia
Apr 23, 2025 11:48am
Sponsored
Fortrea’s Gani Chico Talks Oncology Innovation, AI and Clinical Trial Strategy
Apr 21, 2025 8:00am
Genentech builds autoimmune Repertoire with $765M deal
Apr 23, 2025 7:00am
Vanda sues FDA over months-long hearing delay
Apr 23, 2025 10:33am
Bayer boosts precision oncology efforts with multiyear AI deal
Apr 23, 2025 12:55pm
Intuitive posts strong 1Q earnings as tariffs squeeze margins
Apr 23, 2025 11:00am
More News
Tempus AI in line for $200M from AstraZeneca cancer model deal
Apr 23, 2025 9:01am
Boehringer slots synthetic lethal program into oncology pipeline
Apr 23, 2025 7:45am
Ascletis sees no benefit to high, fast oral GLP-1 dose titration
Apr 23, 2025 7:25am
Sanofi hands cancer drug to Innate as it pivots R&D pact focus
Apr 23, 2025 6:35am